Latham & Watkins Advises on Medline Inc.’s US$3.5 Billion Secondary Offering

Medline Inc. (Nasdaq: MDLN) closed on March 10, 2026, its secondary offering of 86,250,000 shares of its Class A common stock, including the full exercise by the underwriters of their option to purchase up to an additional 11,250,000 shares. All of the shares of Class A common stock were sold by certain selling stockholders affiliated with Blackstone Inc., The Carlyle Group Inc., Hellman & Friedman LLC, and a wholly owned subsidiary of the Abu Dhabi Investment Authority at a price to the public of US$41.00 per share.

Latham & Watkins LLP represented the underwriters in the offering with a corporate team led by partners Jason Licht, Patrick Shannon, Cathy Birkeland, and counsel Christopher Cronin, with associates Ben Winnett, Chelsea Carlson, Caroline Hughes, and Andrew Johnson. Advice was also provided on tax matters by partner Christine Mainguy, with associate Nolon Blaylock; and on FINRA and regulatory matters by partner Gail Neely and corporate attorney Marta Talarek.